Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Q32 Bio Inc. (QTTB) ownership amendment reports that Sirenia Capital Management LP and Alex Silverstein, managing member of Sirenia’s general partner, each report shared voting and dispositive power over the same 1,025,654 shares issuable upon exercise of warrants held by the Sirenia Fund. Each reports beneficial ownership of 4.2% of the class.
The percentage calculation uses 23,681,415 shares, comprising 16,956,415 shares outstanding as of May 26, 2026, plus 6,725,000 shares issued in a private placement entered into that day, and assumes exercise of the Sirenia Fund’s warrants. The amendment restates an earlier amendment to correct prior ownership disclosure; it also says the report is not an admission of beneficial ownership for Exchange Act purposes.
Key Figures
Shares issuable upon warrant exercise:1,025,654 sharesReported beneficial ownership:4.2%Aggregate shares used in percentage calculation:23,681,415 shares+2 more
5 metrics
Shares issuable upon warrant exercise1,025,654 sharesSirenia Capital Management LP and Alex Silverstein each report shared voting and dispositive power over the same shares.
Reported beneficial ownership4.2%Reported by each reporting person, based on the stated aggregate share count and assuming exercise of the Sirenia Fund’s warrants.
Aggregate shares used in percentage calculation23,681,415 sharesThe calculation assumes exercise of the Sirenia Fund’s warrants.
Shares outstanding16,956,415 sharesAs of May 26, 2026, as reported in the issuer’s May 27, 2026 Form 8-K.
Shares issued in private placement6,725,000 sharesIssued in the private placement entered into on May 26, 2026.
"correct the beneficial ownership disclosed therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Powerregulatory
"Shared Voting Power 1,025,654.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 1,025,654.00"
warrantsfinancial
"shares are issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
private placementfinancial
"shares issued in the private placement entered into on May 26, 2026"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many QTTB shares did Sirenia Capital Management LP and Alex Silverstein report?
They each reported beneficial ownership of 1,025,654 shares issuable upon exercise of warrants held by the Sirenia Fund. Each reported shared voting and dispositive power over those shares and ownership equal to 4.2% of the class.
How was the 4.2% QTTB ownership figure calculated?
The calculation used an aggregate of 23,681,415 shares: 16,956,415 shares outstanding as of May 26, 2026, plus 6,725,000 shares issued in the private placement entered into on May 26, 2026. It assumes exercise of warrants held by the Sirenia Fund.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Q32 Bio Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
746964105
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
746964105
1
Names of Reporting Persons
Sirenia Capital Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,025,654.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,025,654.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,025,654.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
IA, PN
Comment for Type of Reporting Person: The 1,025,654 shares of Common Stock (as defined in Item 2(a)) are issuable upon exercise of warrants. This Amendment No. 2 to the Schedule 13G amends and restates the Schedule 13G/A filed on August 14, 2026 to correct the beneficial ownership disclosed therein.
SCHEDULE 13G
CUSIP Number(s):
746964105
1
Names of Reporting Persons
Alex Silverstein
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,025,654.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,025,654.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,025,654.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: The 1,025,654 shares of Common Stock are issuable upon exercise of warrants. This Amendment No. 2 to the Schedule 13G amends and restates the Schedule 13G/A filed on August 14, 2026 to correct the beneficial ownership disclosed therein.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Q32 Bio Inc.
(b)
Address of issuer's principal executive offices:
830 Winter Street, Waltham, Massachusetts 02451
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Sirenia Capital Management LP ("Sirenia") with respect to the common stock, par value $0.0001 per share ("Common Stock"), of Q32 Bio Inc. (the "Issuer") issuable upon exercise of warrants held by an investment fund it manages (the "Sirenia Fund"); and
(ii) Alex Silverstein ("Mr. Silverstein"), the managing member of Sirenia Capital Management GP LLC, the general partner of Sirenia, with respect to the Common Stock issuable upon exercise of warrants held by the Sirenia Fund.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of Sirenia and Mr. Silverstein is 1674 Meridian Avenue, Suite 320, Miami Beach, FL 33139.
(c)
Citizenship:
Sirenia is a Delaware limited partnership. Mr. Silverstein is a United States citizen.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
746964105
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 23,681,415 shares of Common Stock outstanding, which is the sum of (i) 16,956,415 shares of Common Stock outstanding as of May 26, 2026, as reported in Exhibit 10.1 attached to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2026 (the "May 27th 8-K"); and (ii) 6,725,000 shares of Common Stock issued in the private placement entered into on May 26, 2026, as described in the May 27th 8-K, and assumes the exercise of the warrants held by the Sirenia Fund.
(b)
Percent of class:
4.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a).
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Item 2(a) and Item 3.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Sirenia Capital Management LP
Signature:
/s/ Kolby Loft
Name/Title:
Kolby Loft, General Counsel & Chief Compliance Officer